Buscar
Mostrando ítems 1-10 de 349
Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
(SPRINGERNEW YORK, 2012)
Rationale Cannabidiol, the main nonpsychotropic constituent of Cannabis sativa, possesses a large number of pharmacological effects including anticonvulsive, sedative, hypnotic, anxiolytic, antipsychotic, anti-inflammatory, ...
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
(Frontiers Media Sa, 2018)
Movement disorders such as Parkinson's disease and dyskinesia are highly debilitating conditions linked to oxidative stress and neurodegeneration. When available, the pharmacological therapies for these disorders are still ...
Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala
(WILEY-BLACKWELL, 2011)
Objective: Cannabidiol is a chemical constituent from Cannabis sativa and it has multiple mechanisms of action, including antidepressant effects. The main objective of the present study was to evaluate behavioural and ...
Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm
(NATURE PUBLISHING GROUPLONDON, 2013-08-02)
Several pharmacological targets have been proposed as modulators of panic-like reactions. However, interest should be given to other potential therapeutic neurochemical agents. Recent attention has been given to the potential ...
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug
(ASSOC BRASILEIRA PSIQUIATRIASÃO PAULO, 2012-06)
Objectives: To review and describe studies of the non-psychotomimetic constituent of Cannabis sativa, cannabidiol (CBD), as an anxiolytic drug and discuss its possible mechanisms of action. Method: The articles selected ...
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study
(2019)
Recent evidence has raised in discussion the possibility that cannabidiol can act as a negative allosteric modulator of the cannabinoid type 1 receptor. Here we have used computational methods to study the modulation exerted ...
Análisis del proceso de producción de cannabis medicinal con alto porcentaje de Cannabidiol
(Universidad Católica San PabloPE, 2020)
Se sabe que la demanda de Cannabis medicinal no es cubierta por las empresas
productoras debido al crecimiento agigantado del mercado. Existen diversos factores
por el cual la oferta es mínima, ya que el desconocimiento ...
A compatibility study between cannabidiol and pharmaceutical excipients commonly used in lipid systems by thermal analysis and fourier transform infrared spectroscopy
(Universidade Federal do Rio Grande do NorteBrasilUFRNFarmácia, 2019-11)